🇺🇸 FDA

Drug profile · INN

linagliptin and metformin hydrochloride

LINAGLIPTIN AND METFORMIN HYDROCHLORIDE

approved
US status
approved
Patents linked
0
News articles
0

Quick answer

linagliptin and metformin hydrochloride (LINAGLIPTIN AND METFORMIN HYDROCHLORIDE) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN linagliptin and metformin hydrochloride
Brand LINAGLIPTIN AND METFORMIN HYDROCHLORIDE
Route ORAL
Formulation TABLET

Frequently asked questions

What is linagliptin and metformin hydrochloride?

linagliptin and metformin hydrochloride (LINAGLIPTIN AND METFORMIN HYDROCHLORIDE) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for linagliptin and metformin hydrochloride?

LINAGLIPTIN AND METFORMIN HYDROCHLORIDE is a marketed brand name for linagliptin and metformin hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of linagliptin and metformin hydrochloride?

linagliptin and metformin hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.